Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pulse Biosciences CS
(NQ:
PLSE
)
21.48
-0.05 (-0.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pulse Biosciences CS
< Previous
1
2
3
4
5
6
7
8
9
Next >
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 29, 2023
Via
Benzinga
Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 29, 2023
Gainers Axcella Health Inc. (NASDAQ: AXLA) shares climbed 196% to $0.3335 after the company announced it was granted a patent for long COVID fatigue treatment.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Why NovoCure Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 28, 2023
Gainers Mobile Infrastructure Corporation (NASDAQ: BEEP) shares jumped 98.7% to $12.02.
Via
Benzinga
Recap: Pulse Biosciences Q1 Earnings
May 11, 2023
Via
Benzinga
Pulse Biosciences Clarifies Details of Recent S-3 Filing
August 24, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results
August 10, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
July 28, 2023
Via
Benzinga
Pulse Biosciences Schedules Second Quarter 2023 Financial Results Conference Call for August 10, 2023
July 27, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
A Preview Of Pulse Biosciences's Earnings
March 29, 2023
Via
Benzinga
Earnings Scheduled For August 10, 2023
August 10, 2023
Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via
Benzinga
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
July 31, 2023
Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report.
Via
Benzinga
Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting
May 18, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
May 11, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Over $65M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
May 11, 2023
Although US stocks closed mixed on Wednesday, there were a few notable insider trades.
Via
Benzinga
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
May 10, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer
May 03, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces $65 Million Private Placement
May 01, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Schedules First Quarter 2023 Financial Results Conference Call for May 11, 2023
April 27, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
April 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 31, 2023
Via
Benzinga
Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
March 30, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Earnings Scheduled For March 30, 2023
March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.
Via
Benzinga
Latest Executive Changes In Marijuana Industry, New Appointments & Resignations
March 13, 2023
As the Benzinga Cannabis Capital Conference returns to Miami (April 11-12), gathering top CEOs, investors and leaders in the mari
Via
Benzinga
Pulse Biosciences Schedules Fourth Quarter & Full Year 2022 Financial Results Conference Call for March 30, 2023
March 02, 2023
From
Pulse Biosciences, Inc.
Via
Business Wire
Pulse Biosciences Announces Its Novel Nanosecond Pulsed Field Ablation System Will Be Highlighted at the 2023 AF Symposium
February 02, 2023
From
Pulse Biosciences
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 06, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
December 02, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 25, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 24, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.